Home > News > Funds Find Nanotech Alluring But Still Risky
November 14th, 2003
Funds Find Nanotech Alluring But Still Risky
Despite getting a heap of hype, the emerging field of nanotechnology still has a ways to go to reach the mainstream. Nanotech materials and devices are built on a molecular scale. Some scientists say nanomachines will let engineers create nearly anything by arranging molecules with atomic precision. That might be so, but it's many years ahead. So said a panel of venture capital executives who have invested in nanotech companies. They gathered last month at a conference hosted by the nonprofit Foresight Institute of Palo Alto, Calif.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014